STENHOUSE MARK (Chief Operating Officer) purchased 14K shares of PROMETHEUS BIOSCIENCES, INC. on the open market
Open‑market purchase worth $266.0K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/16/2021ACC: 0001209191-21-021219
Officer· Chief Operating Officer
Since Mar 2021
+14K
Net shares
Net buyer
$266.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
14K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+14K
Price / share
$19.00
Trade value
$266K
% of position
New position
3/16/2021
0.00→14K
Total
Net shares
+14K
Net value
$266K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/16/2021 | P · Purchase | +14K | $19.00 | $266K | New position | 0.00 | 14K |
| Total | +14K | $266K | ||||||
Derivative Transactions0
No derivative transactions reported